Korea United Pharm Inc. (KRX:033270)
South Korea · Delayed Price · Currency is KRW 18,620
-10 (-0.05%)
Jan 9, 2026, 3:30 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 273.95 billion as of January 9, 2026. Its market cap has increased by 3.69% in one year.
Market Cap
273.95B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
14.77
Stock Price
18,620.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 273.95B, an increase of 700.63%. That is a compound annual growth rate of 8.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 273.95B | -2.36% |
| Dec 30, 2025 | 280.57B | 4.73% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.26T |
| Celltrion | 46.60T |
| ALTEOGEN | 25.59T |
| ABL Bio | 11.88T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.46T |
| HLB Co., Ltd. | 6.66T |
| LigaChem Biosciences | 6.62T |